コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ell lymphopenia were evaluated by a clinical immunologist.
2 ng developmental biologist to devoted T cell immunologist.
3 actical diagnostic approach for the clinical immunologist.
4 tients are likely to present to an allergist/immunologist.
5 ically inaccessible to the non-computational immunologist.
6 euroscientists, developmental biologists and immunologists.
7 dentified previously in turf grass pollen by immunologists.
8 was originally a problem of concern only to immunologists.
9 ses remain one of the mysteries that perplex immunologists.
10 st material was sent to 1,017 allergists and immunologists.
11 hip Program for Computational Scientists and Immunologists.
12 ir discovery, neutrophils continue to puzzle immunologists.
13 lational diagnostic and prognostic tools for immunologists.
14 g the consensus of at least four experienced immunologists.
15 2-28, 2020, as a global celebration of Black immunologists.
16 educators to enhance the training of future immunologists.
17 mmune response has long been a focus of many immunologists.
18 linical use has become an important goal for immunologists.
19 has more recently attracted the attention of immunologists.
20 id (polySia), has been largely overlooked by immunologists.
23 ure president of the American Association of Immunologists, a JEM Advisory Editor, has been awarded n
26 mune cells in cancer, a chasm exists between immunologists and biologists: although sharing a common
28 combined efforts of clinicians, geneticists, immunologists and cell biologists are producing rapid pr
30 of how concepts that grew out of efforts by immunologists and dermatologists to understand immune re
31 will discuss what immune imprinting means to immunologists and describe efforts to overcome or silenc
32 ppreciated, this duality continues to puzzle immunologists and has implications for the development o
33 rogram is forging new collaborations between immunologists and infectious disease experts and is rein
35 ding how this is accomplished has fascinated immunologists and microbiologists for many years, but th
36 By providing answers to these questions, immunologists and neurobiologists increasingly expose th
37 f 'neuroimmunology' has--for both mainstream immunologists and neuroscientists alike--often seemed mo
40 aradox of fetomaternal tolerance has puzzled immunologists and reproductive biologists alike for almo
41 occasional serendipity, and the present-day immunologists and surgeons exploring immune transplant t
43 is study, we provide a primer on malaria for immunologists and, in this context, review progress iden
47 Collaboration among medical oncologists, immunologists, and neurobiologists in the cancer neurosc
49 vided, and collaboration with hepatologists, immunologists, and pathologists is emphasized as a requi
52 e has begun to impact how vaccinologists and immunologists approach early pre-clinical vaccine develo
61 al biologists to trace the origins of cells, immunologists are turning to fate-mapping to better unde
63 er is of broad interest to hematologists and immunologists as it illuminates the role of donor T cell
64 ese performance metrics provide guidance for immunologists as to which prediction methods to use, and
65 ling is a useful addition to the tool set of immunologists, as it has extra features that allow for s
67 the time, it revolutionized the thinking of immunologists because it provided a simple explanation f
69 so known as NFIL3) was of little interest to immunologists, being best known for its role in regulati
71 work intends to provide a tool not only for immunologists but also for primary care physicians and o
72 r (EAI) prescription or visited an allergist/immunologist, but more likely to have had an ED visit/ho
79 consisted of practicing medical oncologists, immunologists, clinical researchers, biostatisticians, a
82 experimental, structural, and computational immunologists define commonly used terms associated with
83 luation of what Janeway famously called 'the immunologists dirty secret', that humoral immune reactio
84 d the study of antimicrobial agents can help immunologists discover targets and mechanisms of host im
85 layed by key molecules already well known to immunologists (e.g., complement and components of the ma
88 utine tool used by clinical pathologists and immunologists for diagnosis and monitoring of patients w
89 ents the basis of a dilemma that has stumped immunologists for many years, how are self-specific T ce
91 hroughs have brought IPC to the attention of immunologists for their role in innate immunity and in s
92 by neuroscientists and the immune system by immunologists, fuelling the notion that these systems re
93 (COVID-19) pandemic can be developed into an immunologists' guide for preparedness for future pandemi
102 To appreciate the diverse ways in which immunologists have contributed, Nature Reviews Immunolog
116 ugs and Contrast Media and expert allergists/immunologists including members of the Adverse Reactions
117 cians, including a board-certified allergist/immunologist, independently reviewed each potential case
120 upported through The American Association of Immunologists Intersect Fellowship Program for Computati
122 any cases, which suggests that the allergist/immunologist is the appropriate specialist for these pat
127 gens exist, the central dilemma facing tumor immunologists is why the host immune response is so inef
128 osphorylation have been intensely studied by immunologists, less attention has been paid to the impac
129 intensive care, during which allergists and immunologists may encounter patients with these unique t
132 t domain experts such as microbiologists and immunologists need to vet candidate results for follow-u
134 empt to address two questions often asked by immunologists not familiar with the field: what do scaff
135 s longstanding fact, it may be surprising to immunologists of a younger vintage, particularly those w
136 l host immunity are challenges that clinical immunologists often face in their quest to establish a s
137 Although discussions to improve training for immunologists often focus on graduate programs, there ar
138 man studies are sometimes neglected by mouse immunologists, on the basis of the uncontrolled conditio
139 use studies are sometimes neglected by human immunologists, on the basis that mice are not humans and
140 95% CI, 0.53-0.78) or visiting an allergist/immunologist (OR, 0.78; 95% CI, 0.63-0.95) before the in
141 , and with involvement of immunogeneticists, immunologists, other basic scientists, biostatisticians,
142 oma antigens has been a major focus of tumor immunologists over the past two decades, and a broad arr
143 alsalva, Scarpa, and Hunter, to contemporary immunologists Owen, Medawar, and Billingham, and to lege
144 alsalva, Scarpa, and Hunter, to contemporary immunologists Owen, Medawar, and Billingham, and to lege
145 of the T(H)17 pathway illuminates a shift in immunologists' perspectives regarding the basis of tissu
146 sease modeling, pharmaceuticals to vaccines, immunologists play a crucial role in translating basic s
148 ildren with JIA-associated uveitis to ocular immunologists prepared to move on to systemic immunomodu
151 navia has 1000 different words for reindeer, immunologists recognize the range of fates available for
152 percent (946 of 3281) of surveyed allergists/immunologists responded, and 87.1% (825 of 946) of respo
156 ass I multimers are staple components of the immunologist's toolbox, enabling reliable quantification
157 y now familiar and trusted components of the immunologist's toolbox, their application to models of m
160 MHC therefore provides unique advantages for immunologists seeking to confidently validate antigenic
164 ecent advances and availability of datasets, immunologists should take a closer look at the role for
171 hallenges represents a call to arms of basic immunologists to advance our knowledge of malaria immuni
172 w molecular and genetic tools are empowering immunologists to answer longstanding unresolved question
173 w technologies, make it the perfect time for immunologists to be involved in designing the next gener
174 Technological advances are now allowing immunologists to correlate data obtained in vitro with i
176 his Review may help chemists, biologists and immunologists to design the next generation of molecular
177 obic microbial lipid antigens has challenged immunologists to explain, in molecular terms, the nature
179 ists generated tools for microbiologists and immunologists to explore whether autophagy contributes t
180 ened a workshop of malaria investigators and immunologists to foster collaborations and attract more
182 cribe emerging technologies that might allow immunologists to leverage this valuable tool and expand
185 energetically expensive, leading ecological immunologists to postulate that they might participate i
187 The Empowering Next Generation Allergist/immunologist toward Global Excellence Task Force (ENGAGE
188 s mechanisms of lymphatic contraction (which immunologists traditionally do not take into account), a
190 d use by immuno-informaticians, virologists, immunologists, vaccine developers, and other scientists
191 are (ie, EAI prescription fill and allergist/immunologist visit) was associated with a significantly
194 icle provides the perspective of a molecular immunologist who became a transplant patient after many
196 immunology, and create a community of Black immunologists who can support each other to flourish des
200 obiologists, have important implications for immunologists who wish to understand how indigenous micr
201 ed vertebrates (gnathostomes) provides every immunologist with a bird's eye view of how human immunog
202 ed novel packages can be overwhelming to the immunologist with limited computational background.
203 ermingle the perspectives and work of cancer immunologists with cancer biologists and pharmacologists
204 ater forgotten, have come back to haunt many immunologists with new recognition of the importance of
205 " levels of the normal eye surface have left immunologists wondering whether a true microbiome exists
206 ainst a specific immunogen in many vaccines, immunologists would agree that immune responses are subo